A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States

References

• Ahdieh-Grant L. Tarwater P.M. Schneider M.F. Anastos K. Cohen M. Khalsa A. Greenblatt R.M. & Women's Interagency HIV Study 2005 Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study Journal of Acquired Immune Deficiency Syndrome 38 4 500 – 503 .
   PubMed Web of Science ®Google Scholar
• Board on Health Promotion and Disease Prevention [HPDP] 2005 . Public financing and delivery of HIV/AIDS care: Securing the legacy of Ryan white . Washington , DC : The Institute of Medicine, The National Academies Press .
   Google Scholar
• Braithwaite R.S. Kozal M.J. Chang C.C. Roberts M.S. Fultz S.L. Goetz M.B. Justice A.C. 2007 Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies AIDS (London, England) 21 12 1579 – 1589
   PubMed Web of Science ®Google Scholar
• Charlson , M.E. , Pompei , P. , Ales , K.L. and MacKenzie , C.R. 1987 . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation . Journal of Chronic Diseases , 40 ( 5 ) : 373 – 383 .
   PubMedGoogle Scholar
• Clark , R.A. and Squires , K.E. 2005 . Gender-specific considerations in the antiretroviral management of HIV-infected women . Expert Review of Anti-Infective Therapy , 3 ( 2 ) : 213 – 227 .
   PubMedGoogle Scholar
• Cramer , J.A. , Roy , A. , Burrell , A. , Fairchild , C.J. , Fuldeore , M.J. , Ollendorf , D.A. and Wong , P.K. 2008 . Medication compliance and persistence: Terminology and definitions . Value Health , 11 ( 1 ) : 44 – 47 .
   PubMed Web of Science ®Google Scholar
• Crystal , S. , Sambamoorthi , U. , Moynihan , P.J. and McSpiritt , E. 2001 . Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS . Journal of General Internal Medicine , 16 ( 12 ) : 850 – 859 .
   PubMed Web of Science ®Google Scholar
• Domingo P. Suarez-Lozano I. Torres F. Teira R. Lopez-Aldeguer J. Vidal F. Garrido M. 2008 First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: The SUSKA study, a non-randomized comparison from the VACH cohort Journal of Antimicrobial Chemotherapy 61 ( 6 ) 1348 – 1358
   PubMed Web of Science ®Google Scholar
• Elzi L. Marzolini C. Furrer H. Ledergerber B. Cavassini M. Hirschel B. Battegay M. & Swiss HIV Cohort study 2010 Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 Archives of Internal Medicine 170 ( 1 ) 57 – 65
   PubMed Web of Science ®Google Scholar
• Glass T.R. Battegay M. Cavassini M. De Geest S. Furrer H. Vernazza P.L. & Bucher H.C. Swiss HIV Cohort Study 2010 Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study Journal of Acquired Immune Deficiency Syndromes 54 ( 2 ) 197 – 203
   PubMed Web of Science ®Google Scholar
• Kempf , M.C. , Pisu , M. , Dumcheva , A. , Westfall , A.O. , Kilby , J.M. and Saag , M.S. 2009 . Gender differences in discontinuation of antiretroviral treatment regimens . Journal of Acquired Immune Deficiency Syndrome , 52 ( 3 ) : 336 – 341 .
   PubMed Web of Science ®Google Scholar
• Lazo M. Gange S.J. Wilson T.E. Anastos K. Ostrow D.G. Witt M.D. & Jacobson L.P. 2007 Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women Clinical Infectious Diseases 45 ( 10 ) 1377 – 1385
   PubMed Web of Science ®Google Scholar
• Li X. Margolick J.B. Conover C.S. Badri S. Riddler S.A. Witt M.D. & Jocobson L.P. 2005 Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study Journal of Acquired Immune Deficiency Syndrome 38 ( 3 ) 320 – 328
   PubMed Web of Science ®Google Scholar
• Youle M. Mocroft A. Moore A. Sabin C.A. Madge S. Lepri A.C. Phillips A.N. 2001 Reasons for modification and discontinuation of antiretrovirals: Results from a single treatment centre AIDS (London, England) 15 ( 2 ) 185 – 194
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents . ( 2009 December, 1 ). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents . Department of Health and Human Services. Retrieved from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
   Google Scholar
• Spire , B. , Carrieri , P. , Garzot , M.A. , L'henaff , M. and Obadia , Y. 2004 . Factors associated with efavirenz discontinuation in a large community-based sample of patients . AIDS Care , 16 ( 5 ) : 558 – 564 .
   PubMed Web of Science ®Google Scholar
• van Roon , E.N. , Verzijl , J.M. , Juttmann , J.R. , Lenderink , A.W. , Blans , M.J. and Egberts , A.C. 1999 . Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology , 20 ( 3 ) : 290 – 294 .
   PubMedGoogle Scholar
• Vo T.T. Ledergerber B. Keiser O. Hirschel B. Furrer H. Battegay M. Weber R. & Swiss HIV Cohort Study 2008 Durability and outcome of initial antiretroviral treatments received during 2000–2005 by patients in the Swiss HIV Cohort Study Journal of Infectious Diseases 197 ( 12 ) 1685 – 1694
   PubMed Web of Science ®Google Scholar
• Willig J.H. Abroms S. Westfall A.O. Routman J. Adusumilli S. Varshney M. Mugavero M.J. 2008 Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy AIDS (London, England) 22 ( 15 ) 1951 – 1960
   PubMed Web of Science ®Google Scholar